The role of galactosyltransferases in cell surface functions and in the immune system

Drug News and Perspectives

Volumn 19, Issue 7, 2006, Pages 401-409

  Brockhausen, Inka ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1, 4 GALACTOSYLTRANSFERASE 1; GALACTOSE; GALACTOSYLTRANSFERASE; GALECTIN; GLYCOLIPID; GLYCOPROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; LECTIN; N ACETYLGALACTOSAMINE; SELECTIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD GROUP LEWIS SYSTEM; CELL ADHESION; CELL SURFACE; HUMAN; IMMUNE SYSTEM; KIDNEY DISEASE; RHEUMATOID ARTHRITIS; XENOTRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; ANTIGENS, VIRAL, TUMOR; CELL ADHESION; CELL MEMBRANE; GALACTOSE; GALACTOSYLTRANSFERASES; GALECTINS; HUMANS; IMMUNE SYSTEM; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; LECTINS; LEWIS BLOOD-GROUP SYSTEM; RECEPTORS, IMMUNOLOGIC; SELECTINS; TRANSPLANTATION, HETEROLOGOUS; TRISACCHARIDES;

EID: 33750530797     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2006.19.7.1021491     Document Type: Article

References (77)

1. Weis, W.I., Taylor, M.E. and Drickamer, K. The C-type lectin superfamily in the immune system. Immunol Rev 1998, 163: 19-34.
2. Hennet, T. The galactosyltransferase family. Cell Mol Life Sci 2002, 59: 1081-95.
3. Breton, C., Bettler, E., Joziasse, D.H., Geremia, R.A. and Imberty, A. Sequence-function relationships of prokaryotic and eukaryotic galactosyltransferases. J Biochem 1998, 123: 1000-9.
4. Breton, C., Snajdrova, L., Jeanneau, C., Koca, J. and Imberty, A. Structures and mechanisms of glycosyltransferases. Glycobiology 2006, 16: 29R-37R.
5. Berger, E.G. and Rohrer, J. Galactosyltransferase-still up and running. Biochimie 2003, 85: 261-74.
6. Brockhausen, I., Schutzbach, J. and Kuhns, W. Glycoproteins and their relationship to human disease. Acta Anat 1998, 161: 36-78.
7. Brockhausen, I. Glycodynamics of mucin biosynthesis in gastrointestinal tumour cells. Adv Exp Med Biol 2003, 535: 163-88.
8. Brockhausen, I. and Kuhns, W. Glycoproteins and human disease. Medical Intelligence Unit, CRC Press and Mosby Year Book, Chapman & Hall, New York 1997.
9. Hollingsworth, M.A. and Swanson, B.J. Mucins in cancer: Protection and control of the cell surface. Nat Rev 2004, 4: 45-60.
10. Kannagi, R. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. Curr Opin Struct Biol 2002, 12: 599-608.
11. Garcia-Vallejo, J.J., Van Dijk, W., Van Het Hof, B. et al. Activation of human endothelial cells by tumor necrosis factor-alpha results in profound changes in the expression of glycosylation-related genes. J Cell Physiol 2006, 206: 203-10.
12. Brockhausen, I. Mucin-type O-glycans in human colon and breast cancer: Glycodynamics and functions. EMBO Rep 2006, 7: 599-604.
13. Brockhausen, I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999, 1473: 67-95.
14. Sotiriadis, J., Shin, S.C., Yim, D., Sieber, D. and Kim, Y.B. Thomsen-Friedenreich (T) antigen expression increases sensitivity of natural killer cell lysis of cancer cells. Int J Cancer 2004, 111: 388-97.
15. Springer, G.F., Desai, P.R., Spencer, B.D., Tegtmeyer, H., Carlstedt, S.C. and Scanlon, E.F. T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced breast carcinoma. Cancer Detect Prev 1995, 19: 374-80.
16. Lo-Man, R., Vichier-Guerre, S., Perraut, R. et al. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res 2004, 64: 4987-94.
17. Wright, A. and Morrison, S.L. Effect of C2-associated carbohydrate structure on Ig effector function: Studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. J Immunol 1998, 160: 3393-102.
18. Valladeau, J., Duvert-Frances, V., Pin, J.J. et al. Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol 2001, 167: 5767-74.
19. Aarnoudse, C.A., Garcia-Vallejo, J.J., Saeland, E. and van Kooyk, Y. Recognition of tumor glycans by antigen-presenting cells. Curr Opin Immunol 2006, 18: 105-11.
20. van Gisbergen, K.P., Aarnoudse, C.A., Meijer, G.A., Geijtenbeek, T.B. and van Kooyk, Y. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res 2005, 65: 5935-44.
21. Fan, E., O'Neal, C.J., Mitchell, D.D. et al. Structural biology and structure-based inhibitor design of cholera toxin and heat-labile enterotoxin. Int J Med Microbiol 2004, 294: 217-23.
22. Ju, T. and Cummings, R.D. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A 2002, 99: 16613-8.
23. Brockhausen, I., Lehotay, M., Yang, J. et al. Glycoprotein biosynthesis in porcine aortic endothelial cells and changes in the apoptotic cell population. Glycobiology 2002, 12: 33-45.
24. Brockhausen, I., Yang, J., Dickinson, N., Ogata, S. and Itzkowitz, S. Enzymatic basis for sialyl-Tn expression in human colon cancer cells. Glycoconj J 1998, 15: 595-603.
25. Thurnher, M., Rusconi, S. and Berger, E.J. Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome. Clin Invest 1993, 91: 2103-10.
26. Qin, W., Zhou, Q., Yang, L.C. et al. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med 2005, 258: 467-77.
27. Ju, T. and Cummings, R.D. Protein glycosylation: Chaperone mutation in Tn syndrome. Nature 2005, 437: 1252.
28. Rudd, P.M., Elliott, T., Cresswell, P., Wilson, I.A. and Dwek, R.A. Glycosylation and the immune system. Science 2001, 291: 2370-6.
29. Sangeetha, S.R. and Appukuttan, P.S. IgA1 is the premier serum glycoprotein recognized by human galectin-1 since T antigen (GalbetaI→ 3GalNAc-) is far superior to non-repealing N-acetyl lactosamine as ligand. Int J Biol Macromol 2005, 35: 269-76.
30. Xia, L., Ju, T., Westmuckett, A. et al. Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core I-derived 0-glycans. J Cell Biol 2004, 164: 451-9.
31. Yamamoto, F., Clausen, H., White, T., Marken, J. and Hakomori, S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990, 345: 229-33.
32. Keusch, J.J., Manzella, S.M., Nyame, K.A., Cummings, R.D. and Baenziger, J.U. Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipid synthesis, predicts a family of alpha 1,4-glycosyltransferases conserved in plants, insects, and mammals. J Biol Chem 2000, 275: 25315-21.
33. Shinkel, T.A., Chen, C.G., Salvaris, E. et al. Changes in cell surface glycosylation in alpha 1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997, 64: 197-204.
34. Milland, J., Christiansen, D. and Sandrin, M.S. Alpha1,3- galactosyltransferase knockout pigs are available for xenotransplantation: Are glycosyltransferases still relevant? Immunol Cell Biol 2005, 83: 687-93.
35. Galili, U. The alpha-gal epitope (Gal alpha I-3Gal beta 1-4GlcNAc-R) in xenotransplantation. Biochimie 2001, 83: 557-63.
36. Gastinel, L.N., Bignon, C., Misra, A.K., Hindsgaul, O., Shaper, J.H. and Joziasse, D.H. Bovine alpha1,3-galactosyltransferase catalytic domain structure and its relationship with ABO histo-blood group and glycosphingolipid glycosyltransferase. EMBO J 2001, 20: 638-49.
37. Kolb, V., Amann, F., Schmidt, R.R. and Duszenko, M. Specific inhibition of an alpha-galactosyltransferase from Trypanosoma brucei by synthetic substrate analogues. Glycoconj J 1999, 16: 537-44.
38. Holgersson, J. and Lofling, J. Glycosyltransferases involved in type I chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity. Glycobiology 2006, 16: 584-93.
39. Jung, U. and Ley, K. Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. J Immunol 1999, 162: 6755-62.
40. Lemaire, S., Derappe, C., Pasqualetto, V. et al. T lymphocyte activation results in an increased expression of beta-1,4-galactosyltransferase: Phorbol ester induces a similar enhancement in the absence of mitosis. Glycoconj J 1998, 15: 161-8.
41. Yang, X., Lehotay, M., Anastassiades, T., Harrison, M. and Brockhausen, I. The effect of TNF-alpha on glycosylation pathways in bovine synoviocytes. Biochem Cell Biol 2004, 82: 559-68.
42. Mori, R., Kondo, T., Nishie, T., Ohshima, T. and Asano, M. Impairment of skin wound healing in beta-1,4-galactosyltransferase-deficient mice with reduced leukocyte recruitment. Am J Pathol 2004, 164: 1303-14.
43. Asano, M., Nakae, S., Kotani, N. et al. Impaired selectin-ligand biosynthesis and reduced inflammatory responses in beta-1,4- galactosyltransferase-I-deficient mice. Blood 2003, 102: 1678-85.
44. Ellies, L.G., Tsuboi, S., Petryniak, B., Lowe, J.B., Fukuda, M. and Marth, J.D. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity 1998, 9: 881-90.
45. Priatel, J.J., Chui, D., Hiraoka, N. et al. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity 2000, 12: 273-83.
46. Brockhausen, I., Benn, M., Bhat, S. et al. UDP-Gal: GlcNAc-R beta1,4 Galactosyltransferase - a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme. Glycoconj J 2006, 23: 523-39.
47. Qasba, P.K., Ramakrishnan, B. and Boeggeman, E. Substrate-induced conformational changes in glycosyltransferases. Trends Biochem Sci 2005, 30: 53-62.
48. Hansske, B., Thiel, C., Lubke, T. et al. Deficiency of UDP-galactose: N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest 2002, 109: 725-33.
49. Mimura, Y., Sondermann, P., Ghirlando, R. et al. Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J Biol Chem 2001, 276: 45539-47.
50. White, K.D., Cummings, R.D. and Waxman, F.J. Ig N-glycan orientation can influence interactions with the complement system. J Immunol 1997, 158: 426-35.
51. Ollmann Saphire, E., Stanfield, R.L., Crispin, M.D.M. et al. Glycobiology and medicine. In: Advances in Experimental Medicine and Biology. J.S. Axford (Ed.). Kluwer Academic/Plenum, New York 2003, 55-66.
52. Parekh, R.B., Dwek, R.A., Sutton, B.J. et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985, 316: 452-7.
53. Axford, J.S. Glycosylation and rheumatic disease. Biochim Biophys Acta 1999, 1455: 219-29.
54. Moore, J.S., Wu, X., Kulhavy, R. et al. Increased levels of galactose-deficient IgG in sera of HIV-I- infected individuals. AIDS 2005, 19: 381-9.
55. Mizuochi, T., Pastore, Y., Shikata, K. et al. Role of galactosylation in the renal pathogenicity of murine immunoglobulin G3 monoclonal cryoglobulins. Blood 2001, 97: 3537-43.
56. Tsuchiya, N., Endo, T., Matsuta, K. et al. Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG. J Rheumatol 1989, 16: 285-90.
57. Kuroda, Y., Nakata, M., Hirose, S. et al. Abnormal IgG galactosylation in MRL-lpr/lpr mice: Pathogenic role in the development of arthritis. Pathol Int 2001, 51: 909-15.
58. Jeddi, P., Keusch, J., Lydyard, P.M. et al. The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G. Immunology 1999, 98: 475-80.
59. Furukawa, K., Matsuta, K., Takeuchi, F., Kosuge, E., Miyamoto, T. and Kobata, A. Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis. Int Immunol 1990, 2: 105-12.
60. Keusch, J., Lydyard, P.M., Berger, E.G. and Delves, P.J. B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis. Glycoconj J 1998, 15: 1093-7.
61. Varki, A., Angata, T. Siglecs-the major sub-family of I-type lectins. Glycobiology 2006, 16: 1R-27R.
62. Crocker, P.R. Siglecs: Sialic acid-binding immunoglobulin-like lectins in cell-cell interactions and signaling. Curr Opin Struct Biol 2002, 12: 609-15.
63. Rabinovich, G.A. and Gruppi, A. Galectins as immunoregulators during infectious processes: From microbial invasion to the resolution of the disease. Parasite Immunol 2005, 27: 103-14.
64. Cooper, D.N.W. Galectinomics. Biochim Biophys Acta 2002, 1572: 209-31.
65. Liu, F.T. Galectins: Novel anti-inflammatory drug targets. Expert Opin Ther Targets 2002, 6: 461-8.
66. Goletz, S., Hanisch, F.G. and Karsten, U. Novel alphaGalNAc containing glycans on cytokeratins are recognized in vitro by galectins with type II carbohydrate recognition domains. J Cell Sci 1997, 110: 1585-96.
67. Galvan, M., Tsuboi, S., Fukuda, M. and Baum, L.G. Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J Biol Chem 2000, 275: 16730-7.
68. Perillo, N.L., Marcus, M.E. and Baum, L.G. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998, 76: 402-12.
69. Stillman, B.N., Hsu, D.K., Pang, M. et al. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 2006, 176: 778-89.
70. Rabinovich, G.A., Ariel, A., Hershkoviz, R., Hirabayashi, J., Kasai, K.I. and Lider, O. Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1. Immunology 1999, 97: 100-6.
71. Mey, A., Leffler, H., Hmama, Z., Normier, G. and Revillard, J.P. The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J Immunol 1996, 156: 1572-7.
72. Rabinovich, G.A., Toscano, M.A., Ilarregui, J.M. and Rubinstein, N. Shedding light on the immunomodulatory properties of galectins: Novel regulators of innate and adaptive immune responses. Glycoconj J 2004, 19: 565-73.
73. Rabinovich, G.A., Daly, G., Dreja, H. et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999, 190: 385-97.
74. Santucci, L., Fiorucci, S., Rubinstein, N. et al. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 2003, 124: 1381-94.
75. Ochieng, J., Furtak, V. and Lukyanov, P. Extracellular functions of galectin-3. Glycoconj J 2004, 19: 527-35.
76. Leffler, H., Carlsson, S., Hedlund, M., Qian, Y. and Poirier, F. Introduction to galectins. Glycoconj J 2004, 19: 433-40.
77. Keusch, J.J., Manzella, S.M., Nyame, K.A., Cummings, R.D. and Baenziger, J.U. Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids. J Biol Chem 2000, 275: 25308-14.